
Brightlands Venture Partners
Description
Brightlands Venture Partners (BVP) is an independent regional venture capital fund manager strategically located in Geleen, the Netherlands. The firm is deeply integrated into the innovative Brightlands ecosystems, which include campuses focused on materials, life sciences & health, sustainable food, and smart services. BVP's investment strategy is specifically tailored to support and accelerate companies that are active within these high-tech and knowledge-intensive domains, leveraging the region's robust infrastructure and collaborative environment.
BVP primarily targets early-stage and growth-stage companies, providing essential capital for their development and scaling. Their investment approach extends beyond mere financial backing, encompassing strategic guidance and facilitating access to their extensive network within the Brightlands community. The firm is recognized for its participation in seed and Series A rounds, often taking on roles as a lead or co-investor, demonstrating a commitment to fostering long-term partnerships with its portfolio companies.
Brightlands Venture Partners manages several specialized funds, including the Limburg Ventures, Brightlands Agrifood Fund, and Brightlands Smart Services Fund, collectively overseeing more than €100 million in capital. This substantial capital base enables them to support a diverse array of innovative ventures across their target sectors. To date, BVP has invested in over 35 companies, significantly contributing to the economic development and innovation landscape of the southern Netherlands. Their typical investments range from €0.5 million to €5 million per company, reflecting their capacity for impactful, substantial funding.
Investor Profile
Brightlands Venture Partners has backed more than 22 startups, with 3 new investments in the last 12 months alone. The firm has led 12 rounds, about 55% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in The Netherlands, Germany.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
- Typical check size: $540K – $5.4M.
Stage Focus
- Seed (36%)
- Series Unknown (27%)
- Series A (23%)
- Series B (9%)
- Pre Seed (5%)
Country Focus
- The Netherlands (86%)
- Germany (14%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Medical Device
- Food And Beverage
- Product Management
- Recycling
- Life Science
- Sustainability
- Alternative Medicine
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.